r.oyelaran

TL2 · Córdoba

Contributes reviews on supplier material. Based in Córdoba.

Joined 30 November 2024 · last posted 5d

80 posts, newest first. Showing up to 150.

Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #34 · Compounds › Semaglutide · 23 Jul 2026 · 7 likes The oral formulation is a genuinely different pharmaceutical problem from the injectable and shares only the active molecule. Absorption enhancers, fasting requirements…
Reading order for a first week here, and what to skip until later — what changed since Replied, post #71 · Start Here › Welcome · 22 Jul 2026 · 12 likes The arithmetic on Reading order is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
Pancreatitis history and the risk calculus Replied, post #30 · Safety › Contraindications · 18 Jul 2026 · 23 likes Coming back to post #28, because the follow-up matters more than the original answer. Disordered eating history: appetite suppression can trigger relapse in people with…
Seven-day rolling means and why weekly readings mislead Replied, post #41 · Outcomes › Progress reports · 16 Jul 2026 · 3 likes Whatever the answer on seven-day rolling turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the…
How shortages have affected compounding permissions Replied, post #41 · Access › Shortages · 15 Jul 2026 · 6 likes Nothing to add, except that this is the answer I would give if asked.
Historical amylin analogues and what happened to them Replied, post #30 · Compounds › Cagrilintide & amylin analogues · 11 Jul 2026 · 19 likes I read post #28 twice before replying, because I had assumed the opposite. Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #27 · Practice › Dosing & titration · 30 Jun 2026 · 6 likes Split dosing within a week is sometimes proposed to smooth tolerability. With a week-long half-life the concentration is already smooth, so what it would change is the…
Why the timeline is on the right and not the left — what changed since Replied, post #61 · Meta › Site feedback · 24 Jun 2026 · 0 likes Worth separating two things that post #57 runs together. Where the timeline discussion usually stalls is that nobody wants to say "I do not know" and everyone is…
I have no scientific background — can I still follow the analytics categories? Replied, post #25 · Start Here › Welcome · 23 Jun 2026 · 2 likes Useful. I have added it to my own notes with the date on it.
GLP-1 receptor distribution: central and peripheral Replied, post #75 · Pharmacology › Receptor biology · 23 Jun 2026 · 32 likes No disagreement from me. Posting only so the question does not look ignored.
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #44 · Compounds › Secretagogues & GH axis · 21 Jun 2026 · 23 likes Storage: these are lyophilised short peptides and are generally reasonably stable dry and considerably less so in solution. Reconstituting only what will be used within…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #112 · Practice › Reconstitution · 16 Jun 2026 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
Trust level 3 requirements: a clarification — does this still hold? Replied, post #63 · Meta › Announcements · 12 Jun 2026 · 19 likes Questions welcomed: if an announcement is unclear, asking for clarification is welcome. Staff will explain their reasoning. On reflection I would soften that slightly.
Angle of injection and whether 90 degrees is always right — the long version Replied, post #19 · Practice › Administration · 7 Jun 2026 · 10 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #40 · Analytics › Home & field testing · 1 Jun 2026 · 30 likes I have been on both sides of the Reflectance and photometric devices argument in this category within eighteen months, which should tell you how strong the evidence for…
Packaging that arrived damaged: documenting it properly Replied, post #15 · Sourcing › Logistics · 26 May 2026 · 0 likes Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #83 · Outcomes › Body composition · 26 May 2026 · 0 likes Post #82 is right about the mechanism and I think understates the practical bit. Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases…
EU-wide position versus national implementation — what changed since Replied, post #27 · Regional › European Union · 17 May 2026 · 0 likes The honest answer on eu-wide position versus national implementation is that it depends, and the useful part is the list of what it depends on. Four items, in rough…
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #32 · Clinical › Bloodwork · 14 May 2026 · 10 likes Two people in this thread mean different things by Liver enzymes drifting and are disagreeing about the definition while believing they are disagreeing about the facts.…
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #9 · Compounds › Semaglutide · 11 May 2026 · 7 likes Good question, well framed, and I would like to see it answered properly.
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #22 · Analytics › HPLC & UHPLC · 5 May 2026 · 12 likes System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was…
Moderation log format change Replied, post #50 · Meta › Announcements · 5 May 2026 · 16 likes Worth separating two things that post #47 runs together. Supportive, with one reservation worth stating in public: the change makes a common case slightly slower in…
Follow-up: Reconciling a label claim with a content assay Replied, post #18 · Analytics › COA interpretation · 4 May 2026 · 12 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
Request: show the solution author in the topic list — what changed since Replied, post #4 · Meta › Feature requests · 30 Apr 2026 · 0 likes Duplicate requests: if several people request the same feature, the requests often get merged. Check whether your feature has already been suggested before posting.
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #17 · Compounds › Repair & healing peptides · 27 Apr 2026 · 11 likes Mechanistic accounts in this area run well ahead of the outcome data. Angiogenesis and cell migration effects in a dish are real observations and are a long way from a…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #121 · Clinical › Special populations · 23 Apr 2026 · 2 likes I read post #118 twice before replying, because I had assumed the opposite. Where I have landed on pregnancy and pregnancy planning, having got it wrong once in public:…
Follow-up: State-level differences that actually matter Replied, post #5 · Regional › North America · 3 Apr 2026 · 8 likes Nothing in this subcategory is medical or legal advice, and the clinicians posting here say so on their own account. That is the practical version. The rigorous version…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #62 · Lounge › Introductions · 14 Mar 2026 · 1 like Good question, well framed, and I would like to see it answered properly.
Guidelines revision: what changed and why — one year on Replied, post #77 · Meta › Announcements · 2 Mar 2026 · 30 likes That is clearer than the version I had in my head. Thank you.
Trifluoroacetate content and its consequences Replied, post #98 · Analytics › Impurities & related substances · 7 Feb 2026 · 2 likes Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete…
Reused chromatograms across lots: how to spot it — what changed since Replied, post #15 · Analytics › COA interpretation · 3 Feb 2026 · 0 likes Picking up post #12: that is the part I would want checked first. Two claims get bundled together under Reused chromatograms across lots and they need separating. The…
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #11 · Outcomes › Body composition · 28 Jan 2026 · 5 likes I read post #9 twice before replying, because I had assumed the opposite. Neither method is capable of detecting the month-to-month changes that people report detecting…
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #7 · marked as the solution · Evidence › Journal club · 5 Jan 2026 · 7 likes If someone has run SURMOUNT-1 properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
Distinguishing expected GI effects from something that needs urgent attention Replied, post #4 · Practice › Side effects · 30 Dec 2025 · 0 likes This follows the opening post rather than contradicting it. Injection-site reactions are usually local, brief and unremarkable. A reaction spreading over a day, or…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #73 · Compounds › Semaglutide · 20 Dec 2025 · 18 likes Picking up post #70: that is the part I would want checked first. Genuine question rather than a rhetorical one: has anyone here actually observed semaglutide…
Reading an interaction checker output critically Replied, post #70 · Practice › Interactions · 19 Dec 2025 · 1 like Worth separating two things that post #66 runs together. I have no financial interest in anything named in this thread and I want to say so before I comment on reading…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #68 · Compounds › Tirzepatide · 10 Dec 2025 · 0 likes Coming back to post #66, because the follow-up matters more than the original answer. Titration schedules for tirzepatide have more dose steps than semaglutide partly…
Heterogeneity as information rather than as a nuisance Replied, post #9 · Evidence › Meta-analyses · 27 Nov 2025 · 0 likes Post #8 is right about the mechanism and I think understates the practical bit. Study quality and weighting: some meta-analyses weight all studies equally; others…
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #14 · Research Methods › N-of-1 designs · 24 Oct 2025 · 0 likes On post #10 — agreed on the reasoning, with one qualification. Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores)…
New subcategory: rationale and scope Replied, post #37 · Meta › Announcements · 16 Oct 2025 · 1 like Worth separating two things that post #33 runs together. Checked the new subcategory claim against the primary source this morning. It survives, with a narrower scope…
Availability by country, dated, with primary sources Replied, post #19 · Access › International · 13 Oct 2025 · 6 likes The number people quote for availability is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly uninformative…
Sleep quality changes during weight loss — what changed since Replied, post #13 · Wellbeing › Sleep · 30 Sep 2025 · 7 likes This follows post #10 rather than contradicting it. Sleep quality versus quantity: some people report changes to sleep duration; others report changes to sleep quality…
Which panel is worth repeating and which is worth ignoring Replied, post #124 · Clinical › Bloodwork · 29 Sep 2025 · 0 likes Good question, well framed, and I would like to see it answered properly.
Discussing something you have already been doing Replied, post #6 · marked as the solution · Clinical › Prescriber conversations · 18 Sep 2025 · 31 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. The conclusion is tentative;…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #81 · Data & Tools › Datasets · 9 Sep 2025 · 0 likes Worth separating two things that post #77 runs together. Combining results from different testing services into one column loses information that matters. Keep the…
Confounding by indication, explained with a concrete example Replied, post #19 · Evidence › Study critique · 2 Sep 2025 · 12 likes That matches what I have seen, for whatever a single anecdote is worth.
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #9 · Lounge › Off topic · 28 Aug 2025 · 0 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not. That is what I would do. It may not be…
Pages past their review date, listed Replied, post #21 · Meta › Wiki maintenance · 23 Aug 2025 · 2 likes Right — I had this wrong and I am glad to have read it before it mattered.
Coming back to: What published stability data actually covers, and what it does not Replied, post #119 · Practice › Storage & stability · 21 Aug 2025 · 16 likes The reason published stability data actually covers is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #71 · Evidence › Journal club · 20 Aug 2025 · 2 likes On post #68 — agreed on the reasoning, with one qualification. The figures usually contain the finding and the text usually contains the interpretation. Separating them…
Enforcement priorities versus written rules — does this still hold? Started this topic · Sourcing › Regulatory · 5 Aug 2025 · 27 likes Enforcement priorities versus written rules — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Asking what…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #13 · Analytics › COA interpretation · 30 Jul 2025 · 26 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
Gauge and length selection for subcutaneous injection Replied, post #15 · Devices › Syringes & needles · 27 Jul 2025 · 0 likes Post #13 answers the question as asked. The question underneath it is different. Sharps containers are a legal requirement for disposal in several jurisdictions and a…
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #38 · Sourcing › Regulatory · 30 Jun 2025 · 1 like Post #36 answers the question as asked. The question underneath it is different. An indication approved for one age range does not extend to another, and paediatric…
Sodium, potassium and magnesium when intake drops Replied, post #24 · Nutrition & Training › Hydration & electrolytes · 20 Jun 2025 · 0 likes Right — I had this wrong and I am glad to have read it before it mattered.
Pre-registering a personal experiment, seriously Replied, post #90 · Research Methods › N-of-1 designs · 2 Jun 2025 · 1 like Post #87 is right about the mechanism and I think understates the practical bit. An n of one tells you about one person, which is the person you are most interested in.…
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #8 · Evidence › Journal club · 16 May 2025 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
Why "any advice?" is the least effective ending for a post — the long version Replied, post #3 · Start Here › How to Ask · 14 May 2025 · 4 likes If your question has a deadline — a parcel in transit, a delivery you have to accept or refuse — say so. People answer differently when there is a clock on it. It is…
Ipamorelin selectivity claims and where they came from Replied, post #37 · Compounds › Secretagogues & GH axis · 13 May 2025 · 11 likes Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative ileus and was not taken forward to registration.…
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #18 · Evidence › Journal club · 12 May 2025 · 11 likes Source for the STEP 4 figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than the paper…
Excipient function in a licensed injectable Replied, post #5 · marked as the solution · Pharmacology › Formulation chemistry · 7 May 2025 · 20 likes Surfactants such as polysorbate are added to prevent adsorption and aggregation at interfaces. In a bare research preparation there is nothing performing that function.
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #124 · Evidence › Journal club · 23 Apr 2025 · 10 likes Same experience here, different supplier, so it is at least not unique to one of them.
Reconstituting a multi-strength kit without mixing yourself up Replied, post #59 · Practice › Reconstitution · 18 Apr 2025 · 6 likes An honest declaration on reconstituting a multi-strength kit: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather…
A well-designed study with a badly written abstract Replied, post #27 · Evidence › Study critique · 16 Apr 2025 · 2 likes Sensible. I would want the same detail before I acted on it either.
UK access routes, dated and sourced — a second dataset Replied, post #63 · Regional › UK & Ireland · 13 Apr 2025 · 0 likes Anyone quoting an eligibility threshold should say which document it comes from. The thresholds have changed and the old ones are still circulating.
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #74 · Compounds › Semaglutide · 12 Apr 2025 · 16 likes Renal outcomes moved this compound out of the metabolic-only conversation. FLOW reported on kidney endpoints in people with type 2 diabetes and chronic kidney disease,…
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #20 · Compounds › Secretagogues & GH axis · 6 Mar 2025 · 22 likes Picking up post #18: that is the part I would want checked first. A mass result for a short peptide is more discriminating than for a long one, because a single residue…
Reading an MS report that only gives you a single number Replied, post #21 · Analytics › Mass spectrometry · 3 Mar 2025 · 9 likes Resolution and mass accuracy are different specifications. An instrument can resolve two species and still assign their masses imprecisely, and the reverse is also…
A supplier that answers analytical questions with restated claims Replied, post #32 · Sourcing › Red flags · 1 Mar 2025 · 15 likes The most useful contribution to this subcategory is a resolved case written up with the resolution, because the unresolved ones are all anyone remembers. That much is…
Journal club: SURMOUNT-1, read without the press release Replied, post #69 · Evidence › Journal club · 1 Mar 2025 · 26 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.
Pharmaceutical compounding rules, summarised from primary sources Replied, post #16 · Sourcing › Regulatory · 27 Feb 2025 · 0 likes If you can confirm or contradict a position for your own region, please date the answer. An undated regional claim is the least useful thing in this category. I would…
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #56 · Pharmacology › Receptor biology · 19 Feb 2025 · 0 likes Helpful, and easy to find again, which is half of what a good reply is.
Recovery when intake is low: what to cut first Replied, post #13 · Nutrition & Training › Resistance training · 9 Jan 2025 · 24 likes Anybody returning after a break should expect to start lower than they left, and expecting otherwise is where injuries come from.
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #46 · Practice › Interactions · 7 Jan 2025 · 6 likes Two sentences on Grapefruit and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is inferred…
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #3 · Pharmacology › Receptor biology · 10 Dec 2024 · 0 likes GLP-1 receptor agonism produces its metabolic effects through more than one route: central satiety signalling, delayed gastric emptying, and glucose-dependent insulin…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #63 · Access › Insurance & coverage · 10 Dec 2024 · 11 likes Coming back to post #61, because the follow-up matters more than the original answer. Marking my uncertainty on Step therapy requirements explicitly. I am confident…
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #33 · Compounds › Semaglutide · 19 Nov 2024 · 0 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Started this topic · Evidence › Journal club · 4 Nov 2024 · 41 likes The question in the title: Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? I will give what I have already checked below so nobody repeats…
Promotion criteria, and the one that stops most nominations Replied, post #96 · Documentation › Doc review · 26 Oct 2024 · 11 likes Coming back to post #94, because the follow-up matters more than the original answer. Reviewing your own nomination is fine and is not sufficient. Somebody else has to…
Blind submission and why it changes minds Replied, post #34 · Sourcing › Independent verification · 11 Aug 2024 · 11 likes Taking blind submission seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and…